DEPDC1B: A Potential Drug Target for Alzheimer's (G55789)

Target Name: DEPDC1B

NCBI ID: G55789

DEPDC1B

DEPDC1B: A Potential Drug Target for Alzheimer's

DEPDC1B (HBxAg transactivated protein 1) is a protein that is expressed in the brain and is involved in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is a key regulator of the huntingtin gene, which is a well-known protein that is involved in the development and maintenance of neuronal cells.

Research has shown that DEPDC1B is highly expressed in the brains of individuals with Alzheimer's disease and that it is associated with the disease. Studies have also shown that inhibiting the activity of DEPDC1B has been shown to protect against the development and progression of Alzheimer's disease.

The huntingtin gene was first identified in the 1990s and has since been shown to be involved in the development and progression of various neurological disorders, including Alzheimer's disease. The huntingtin gene is a double-stranded transmembrane protein that is composed of four exons. The exons are responsible for encoding the different regions of the protein, including the catalytic domain, the N-terminus, and the C-terminus.

The catalytic domain of DEPDC1B is a critical region of the protein that is involved in its function. The catalytic domain is responsible for the protein's catalytic activity and is involved in the regulation of various cellular processes.

In addition to its role in the huntingtin gene, DEPDC1B is also involved in the regulation of other genes. For example, studies have shown that DEPDC1B is involved in the regulation of the APP尾-1 gene, which encodes a protein that is involved in the development and progression of Alzheimer's disease.

The N-terminus and C-terminus of DEPDC1B are also involved in its function. The N-terminus of the protein is responsible for its ability to interact with other proteins and for its role in the regulation of various cellular processes. The C-terminus of the protein is responsible for its ability to interact with the huntingtin gene and for its role in the regulation of the huntingtin gene.

In conclusion, DEPDC1B is a protein that is involved in the development and progression of Alzheimer's disease. The protein is a key regulator of the huntingtin gene and is highly expressed in the brains of individuals with the disease. Additionally, DEPDC1B is also involved in the regulation of other genes, including the APP尾-1 gene. These findings suggest that DEPDC1B may be a potential drug target or biomarker for the development and treatment of Alzheimer's disease. Further research is needed to fully understand the role of DEPDC1B in the development and progression of Alzheimer's disease.

Protein Name: DEP Domain Containing 1B

The "DEPDC1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEPDC1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets